Drugs and Drug Candidates from Marine Sources: An Assessment of the Current "State of Play".

@article{Newman2016DrugsAD,
  title={Drugs and Drug Candidates from Marine Sources: An Assessment of the Current "State of Play".},
  author={David J Newman and Gordon M Cragg},
  journal={Planta medica},
  year={2016},
  volume={82 9-10},
  pages={
          775-89
        }
}
The potential of the marine environment to produce candidate compounds (structures) as leads to, or even direct drugs from, has been actively discussed for the last 50 or so years. Over this time frame, several compounds have led to drugs, usually in the area of cancer (due to funding sources). This review is designed to show where there have been successes, but also to show that in a number of disease areas, there are structures originally isolated from marine invertebrates and free-living… Expand
Marine drugs for cancer: surfacing biotechnological innovations from the oceans
TLDR
The development of these compounds will be discussed herein to illustrate, with successful examples provided by cytarabine, trabectedin, eribulin and brentuximab vedotin, the steps involved in this process as well as the scientific advances and technological innovation potential associated with developing a new drug from marine resources. Expand
Current Status of Marine-Derived Compounds as Warheads in Anti-Tumor Drug Candidates
In this review, we have attempted to describe all of the antibody–drug conjugates using a marine-derived compound as the “warhead”, that are currently in clinical trials as listed in the currentExpand
Marine natural products as source of new drugs: a patent review (2015–2018)
TLDR
Despite the critical supply challenges, marine-derived actives are being explored as sources for anticancer, antimicrobial, antiviral and anti-inflammatory drugs and treatments for several other conditions. Expand
Marine Natural Products: A Source of Novel Anticancer Drugs
TLDR
The impact of marine organisms, with particular emphasis on marine plants, algae, bacteria, actinomycetes, fungi, sponges and soft corals, and the possible molecular mechanisms behind the biological effects are presented. Expand
From natural products to drugs
Abstract It is frequently assumed, particularly in the last 15 plus years, that “Natural Product Structures” are no longer a source of drugs in the twenty-first century. In fact, this is not at allExpand
Marine Enzymes in Cancer: A New Paradigm.
TLDR
The potential utility of marine enzymes in cancer therapy will be discussed in this chapter. Expand
Marine-Derived Pharmaceuticals – Challenges and Opportunities
TLDR
Challenges in drug development from marine sources, especially the supply problem are described, as well as some other products are of interest in diagnostic and as experimental tools. Expand
Screening for marine-derived antivirals
Viruses are accountable for numerous diseases that form an immense threat to public health worldwide. The capability of viruses to continuously adapt to a changing environment makes the discovery ofExpand
Marine bacteria and fungi as promising source for new antibiotics
TLDR
Increasing interest in marine microorganisms as promising producers of new compounds with potential medical applications has raised increasing interest in the sustainable exploration of marine microbial resources for the discovery of new antibiotics, which is highlighted. Expand
Natural Products Repertoire of the Red Sea
TLDR
This review is a comprehensive study that compares the natural products recovered from the Red Sea in terms of ecological role and pharmacological activities. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 187 REFERENCES
Lessons from the past and charting the future of marine natural products drug discovery and chemical biology.
TLDR
Understanding of how these agents are biosynthetically assembled has accelerated in recent years, especially through interdisciplinary approaches, and innovative manipulations and re-engineering of some of these gene clusters are yielding novel agents of enhanced pharmaceutical properties compared with the natural product. Expand
Microbial natural products: molecular blueprints for antitumor drugs
TLDR
This review describes only a handful of exemplary natural products and their derivatives as well as those that have served as elegant blueprints for the development of novel synthetic structures that are either currently in use or in clinical or preclinical trials together with some of their earlier analogs in some cases whose failure to proceed aided in the derivation of later compounds. Expand
Chemical approaches to the discovery of new drugs.
TLDR
This article outlines some of the principles involved in the search for new drugs today discovery from the chemical point of view and illustrates the discussion with many examples of commercial drugs and compounds currently under development. Expand
Chemical approaches to the discovery of new drugs.
TLDR
This article outlines some of the principles involved in the search for new drugs today discovery from the chemical point of view and illustrates the discussion with many examples of commercial drugs and compounds currently under development. Expand
Anticancer Agents from Natural Products, Second Edition
The approach to drug discovery from natural sources has yielded many important new pharmaceuticals inaccessible by other routes. In many cases the isolated natural product may not be an effectiveExpand
Cyanobacteria: potential candidates for drug discovery
TLDR
This review mainly focuses on anticancerous, antiviral and antibacterial compounds from cyanobacteria; their clinical status; extraction and detection techniques; and synthetic analogues with improved bioactivity. Expand
Discovery, synthesis, and structure-activity relationships of conotoxins.
Peptide therapeutics are acclaimed as a promising addition to the pharmaceutical arena, and they continue to attract interest due to their high potency, bioavailability, and fewer concerns withExpand
Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development †
TLDR
This review shows the compounds derived from marine sources that are currently in clinical trials against cancer and the use of marine-derived agents to ameliorate the pain from cancers in humans, and to act as an adjuvant in immunological therapies. Expand
The odyssey of marine pharmaceuticals: a current pipeline perspective.
TLDR
From a global perspective the marine pharmaceutical pipeline remains very active, and now has sufficient momentum to deliver several additional compounds to the marketplace in the near future; this review provides a current view of the pipeline. Expand
Discovery and development of the anticancer agent salinosporamide A (NPI-0052).
TLDR
A chronicle of the important events that facilitated the rapid clinical development of this exciting molecule salinosporamide A (NPI-0052) into human clinical trials is offered. Expand
...
1
2
3
4
5
...